2025 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

Hawai'i Convention Center, Honolulu, HI
February 12-15, 2025
Pre-conference: February 11, 2025; and Post-conference: February 16, 2025

Click HERE to register today!

VISIT THE TANDEM MEETINGS WEBSITE FOR ALL DETAILS PERTAINING TO THE 2025 TANDEM MEETINGS.

ASTCT^® and CIBMTR^® value the views of our community. Diversity, equity, and inclusion (DEI) are core attributes of our organizations, which include supporting members and attendees to ensure high-quality and equitable care for the patients and communities we serve. As we plan for the 2025 Tandem Meetings | Transplantation & Cellular Therapy Meetings and future Tandem Meetings, we advise that the choice to host a meeting in a certain location does not infer support for local laws, policies or candidates. For more information regarding our position on DEI initiatives, view the joint statement.

Through the Tandem Meetings:

• Administrators, clinicians, data managers, clinical research professionals, fellows-in-training, investigators, laboratory technicians, MDs, PhDs, nurses, nurse practitioners, pharmacists, physician assistants, and other allied health professional attendees benefit from a full scientific program that addresses the timeliest issues in hematopoietic cell transplantation (HCT), cellular therapy, and gene therapy.
• Leading experts in the field of HCT, cellular therapy, and gene therapy from around the world will present the latest developments during plenaries, concurrent sessions, oral abstracts, posters, tracks, meet-the-professor sessions, and more;
• ASTCT Spotlight Sessions will focus on cutting-edge clinical and translational research;
• CIBMTR Working Committee meetings will shape the observational research that culminates in peer-reviewed journals that move the field toward improved outcomes and higher quality of life.

What to Expect in 2025:

Access to the latest scientific updates, new technologies, and innovative products in HCT, cellular therapy, and gene therapy.